Immuno-oncology approaches in uveal melanoma: tebentafusp and beyond
Uveal melanoma (UM) is the most common ocular malignancy in adults, associated with the poorest prognosis, with metastatic disease occurring in up to 50% of patients. In contrast to metastatic cutaneous melanoma, the use of immune checkpoint inhibitors is associated with poor outcomes in metastatic...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2023-09-01
|
| סדרה: | Immuno-Oncology and Technology |
| נושאים: | |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S259001882300014X |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|